PREDICTIVE VALUE OF VOIDING DYSFUNCTION SYMPTOM SCORE TO FIND THE RESPONSE TIME TO THE TREATMENT

Abstract

Abstract Purpose Dysfunctional voiding makes the 40% of the patients who admitted pediatric urologists. Voiding dysfunction symptom score (VDSS) is a noninvasive test and has been used for detection or monitoring of these patients. Here in we attempted to find predictive value of VDSS to find the response time to the treatment. Material and Methods Between April 2004–July 2007, 214 patients who admitted to pediatric urology clinic with LUTD was reviewed. VDSS of 9 and upper were pointed. VDSS performed to the patients before and after treatment of 1, 3 and 6 months. Results 22(%64.7) of 34 patients having 10 and lower scores showed improvement at first month of the treatment. 11(%32.4) and remaining 1(%2.9) showed improvement after treatment 3, 6 months. Of the 54 patients with symptom scores 11–15, 35(%64.8) showed improvement at the first month and 18(%33.3) at the 3 rd month. 1 (%1.9) patient showed no improvement. Of the 63 patients with symptom scores 16-20, 2(%3.2) showed improvement at the first month, 44(%69.8) at 3 rd month and 7(%11.1) at 6 th month of treatment. 10(%15.9) patients showed no improvement. 8(%12.7) of 63 patients with scores of 20 and more showed improvement after treatment 3 months. 24(%38.1) showed improvement at 6 th month of treatment and 31(%49.2) patient no improvement. Conclusions This study has been shown that, VDSS is a predictive test to find the response time to the treatment. The higher scores of VDSS show long treatment period and late onset of response to the treatment.